Alembic Pharma gets USFDA nod for Desonide Ointment

Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news